Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 177 entries
View as:

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Phase: N/A Priority: Normal
NCT ID: NCT00583986 Org: User:
Start: 09/30/05 End: 03/31/06 Due: 03/31/07

First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03429218 Org: User:
Start: 07/10/18 End: 03/08/21 Due: 03/08/22

Rifampin Drug-Drug Interaction Study With Lurasidone HCl

Phase: N/A Priority: Normal
NCT ID: NCT01082276 Org: User:
Start: 08/31/08 End: 08/31/08 Due: 08/31/09

A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01774747 Org: User:
Start: 12/31/12 End: 04/30/14 Due: 04/30/15

6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00352144 Org: User:
Start: 10/31/03 End: 10/31/04 Due: 10/31/05

A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06753331 Org: User:
Start: 12/18/24 End: 03/01/29 Due: 03/01/30

A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation

Phase: N/A Priority: Normal
NCT ID: NCT02432690 Org: User:
Start: 06/30/15 End: 01/02/17 Due: 01/02/18

Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02469090 Org: User:
Start: 06/18/15 End: 12/11/17 Due: 12/11/18

A Safety, Efficacy and Tolerability Study of SEP-225289

Phase: N/A Priority: Normal
NCT ID: NCT00584974 Org: User:
Start: 12/31/07 End: 05/31/09 Due: 05/31/10

Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00641745 Org: User:
Start: 03/31/08 End: 07/31/10 Due: 07/31/11

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296

Phase: N/A Priority: Normal
NCT ID: NCT01575561 Org: User:
Start: 06/30/12 End: 07/31/15 Due: 07/31/16

A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT00953147 Org: User:
Start: 08/31/09 End: 05/31/10 Due: 05/31/11

Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00367965 Org: User:
Start: 02/29/04 End: 11/30/04 Due: 11/30/05

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Phase: N/A Priority: Normal
NCT ID: NCT03108729 Org: User:
Start: 07/06/17 End: 10/26/17 Due: 10/26/18

A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02993731 Org: User:
Start: 12/31/16 End: 03/31/20 Due: 03/31/21

A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00583947 Org: User:
Start: 01/31/08 End: 12/31/08 Due: 12/31/09

A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00809757 Org: User:
Start: 12/31/08 End: 06/30/13 Due: 06/30/14

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)

Phase: N/A Priority: Normal
NCT ID: NCT00868699 Org: User:
Start: 04/30/09 End: 02/29/12 Due: 02/28/13

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00073827 Org: User:
Start: 05/31/02 End: 01/31/03 Due: 01/31/04

Open-label Safety Study in Adults With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT02160262 Org: User:
Start: 06/30/14 End: 05/31/16 Due: 05/31/17

An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic Medication

Phase: N/A Priority: Normal
NCT ID: NCT05741528 Org: User:
Start: 03/31/23 End: 01/10/25 Due: 01/10/26

Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL

Phase: N/A Priority: Normal
NCT ID: NCT03572634 Org: User:
Start: 06/10/19 End: 01/21/20 Due: 01/21/21

A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01776307 Org: User:
Start: 03/31/12 End: 04/30/20 Due: 04/30/21

A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02826161 Org: User:
Start: 11/30/16 End: 04/24/17 Due: 04/24/18

Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00235508 Org: User:
Start: 06/30/05 End: 04/30/06 Due: 04/30/07